Title : Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: In vivo activity and mechanisms.

Pub. Date : 2002 Apr

PMID : 11894120






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In LS174T cells, the antisense oligonucleotide, but not the mismatch oligonucleotide, specifically inhibited MDM2 expression, resulting in a significant increase in irinotecan-associated p53 activation and p21 induction. Irinotecan tumor protein p53 Homo sapiens